Convoke raises $8.6M from Kleiner Perkins, Dimension and others.

Insights
Insights

Unlocking innovation in pharma (Invest Like The Best podcast)

Jan 30, 2024

Jan 30, 2024

Listen to co-founder and CEO Alex Telford's conversation with Patrick O'Shaughnessy on the Invest Like The Best podcast. The transcript and audio are available on the Colossus website.

Patrick's summary of the discussion is below:

My guest today is Alex Telford. Alex is the founder of Convoke, a software platform that helps streamline drug development and commercialization. He has also been writing frequent blog posts on the biotech industry since 2019, keeping a pulse on the direction of innovation. He joined me today to talk about the history of the pharmaceutical industry and what's becoming possible in medicine in the coming years.

Alex helped breakdown the complexities of investing in new drug development, breakthroughs in gene therapy on the horizon and the dance between timely progress and restrictive regulation. This industry has a ton to unpack, and Alex thoughtfully lays out the landscape. Please enjoy my conversation with Alex Telford.

Learn how we help teams unlock capacity

Stay updated

Copyright © 2025 Convoke Holdings, Inc.

All rights reserved.

Learn how we help teams unlock capacity

Stay updated

Copyright © 2025 Convoke Holdings, Inc.

All rights reserved.

Learn how we help teams unlock capacity

Stay updated

Copyright © 2025 Convoke Holdings, Inc.

All rights reserved.

Learn how we help teams unlock capacity

Stay updated

Copyright © 2025 Convoke Holdings, Inc.

All rights reserved.